Clinical Scorecard: Understanding Healthcare Providers' Awareness of West Nile Virus Diagnostic Testing in the U.S.—2022
At a Glance
Category
Detail
Condition
West Nile virus (WNV) disease
Key Mechanisms
Mosquito-borne flavivirus infection causing asymptomatic, febrile, or neuroinvasive illness
Target Population
Patients with suspected WNV infection including immunocompetent and immunocompromised individuals
Care Setting
Outpatient and inpatient healthcare settings in the United States
Key Highlights
Only 26% of surveyed U.S. healthcare providers ordered the correct laboratory tests for diagnosing WNV disease in two patient scenarios.
WNV-specific IgM testing in serum or cerebrospinal fluid is the primary diagnostic method; RT-PCR is preferred for immunocompromised patients.
Unnecessary testing is common, leading to excess healthcare costs and potential diagnostic inefficiencies.
Guideline-Based Recommendations
Diagnosis
Use WNV-specific IgM testing of serum or cerebrospinal fluid to diagnose acute infection in immunocompetent patients.
Perform confirmatory plaque reduction neutralization test (PRNT) for severe, atypical cases, or possible cross-reactive flavivirus exposure.
For immunocompromised patients, prefer reverse-transcription polymerase chain reaction (RT-PCR) testing on serum or CSF.
Management
No approved treatments or human vaccines exist; diagnosis informs clinical management and patient prognosis.
Accurate diagnosis supports public health surveillance and implementation of prevention measures such as vector control.
Monitoring & Follow-up
Monitor for neuroinvasive disease manifestations including meningitis, encephalitis, or acute flaccid paralysis in diagnosed patients.
Risks
Underdiagnosis due to insufficient or inappropriate testing can impair patient management and public health response.
Excessive or unnecessary testing increases healthcare costs without improving diagnostic accuracy.
Patient & Prescribing Data
Immunocompetent and immunocompromised patients suspected of WNV infection
Correct diagnostic testing is critical; immunocompromised patients require RT-PCR testing, while immunocompetent patients require IgM testing in serum or CSF.
Clinical Best Practices
Educate healthcare providers on appropriate WNV diagnostic testing to improve clinical management and prognosis.
Select diagnostic tests based on patient immune status to avoid unnecessary testing and reduce costs.
Consider confirmatory testing with PRNT in complex cases or when cross-reactive flavivirus exposure is possible.
Incorporate WNV testing knowledge into routine practice especially in regions with higher WNV incidence.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
